Taysha Gene Therapies Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Taysha Gene Therapies Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Taysha Gene Therapies Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Taysha Gene Therapies Inc. is TSHA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Taysha Gene Therapies Inc. has its primary listing on NASDAQ. You can trade Taysha Gene Therapies Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Taysha Gene Therapies Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Taysha Gene Therapies Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Taysha Gene Therapies Inc..